{"title":"适应糖尿病的远程医疗","authors":"Anaya Malik","doi":"10.33590/emjdiabet/10013792","DOIUrl":null,"url":null,"abstract":"THIS year’s European Association for the Study of Diabetes (EASD) Annual\nMeeting 2022 was a hybrid congress, which focused on inclusion and\ninteraction within the global diabetes community whether participants\nattended in person in Stockholm, Sweden, or virtually.\nIn front of a live audience, Richard Holt, Professor in Diabetes and Endocrinology\nat University of Southampton, UK, delivered the presentation, ‘“I just called to say\nI love you...” Diabetes tools for telemedicine: What we learned from COVID-19 and\nbeyond?’ Holt spoke on how telemedicine has become increasingly popular in\ndiabetes consultations, and how there has been a major rise in its use as a\nresult of the pandemic. Holt reviewed the evidence on telemedicine for diabetes\ncare, before exploring the practical issues experienced by patients and healthcare\nprofessionals during the pandemic, taking these as lessons to better inform how\nwe can use telemedicine going forward. The COVID-19 pandemic has led to a rapid\nexpansion of the use of telemedicine, and many have had to adapt to the use of this\nin diabetes care.","PeriodicalId":418035,"journal":{"name":"EMJ Diabetes","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Adapting to Telemedicine in Diabetes\",\"authors\":\"Anaya Malik\",\"doi\":\"10.33590/emjdiabet/10013792\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"THIS year’s European Association for the Study of Diabetes (EASD) Annual\\nMeeting 2022 was a hybrid congress, which focused on inclusion and\\ninteraction within the global diabetes community whether participants\\nattended in person in Stockholm, Sweden, or virtually.\\nIn front of a live audience, Richard Holt, Professor in Diabetes and Endocrinology\\nat University of Southampton, UK, delivered the presentation, ‘“I just called to say\\nI love you...” Diabetes tools for telemedicine: What we learned from COVID-19 and\\nbeyond?’ Holt spoke on how telemedicine has become increasingly popular in\\ndiabetes consultations, and how there has been a major rise in its use as a\\nresult of the pandemic. Holt reviewed the evidence on telemedicine for diabetes\\ncare, before exploring the practical issues experienced by patients and healthcare\\nprofessionals during the pandemic, taking these as lessons to better inform how\\nwe can use telemedicine going forward. The COVID-19 pandemic has led to a rapid\\nexpansion of the use of telemedicine, and many have had to adapt to the use of this\\nin diabetes care.\",\"PeriodicalId\":418035,\"journal\":{\"name\":\"EMJ Diabetes\",\"volume\":\"11 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EMJ Diabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33590/emjdiabet/10013792\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMJ Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33590/emjdiabet/10013792","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
THIS year’s European Association for the Study of Diabetes (EASD) Annual
Meeting 2022 was a hybrid congress, which focused on inclusion and
interaction within the global diabetes community whether participants
attended in person in Stockholm, Sweden, or virtually.
In front of a live audience, Richard Holt, Professor in Diabetes and Endocrinology
at University of Southampton, UK, delivered the presentation, ‘“I just called to say
I love you...” Diabetes tools for telemedicine: What we learned from COVID-19 and
beyond?’ Holt spoke on how telemedicine has become increasingly popular in
diabetes consultations, and how there has been a major rise in its use as a
result of the pandemic. Holt reviewed the evidence on telemedicine for diabetes
care, before exploring the practical issues experienced by patients and healthcare
professionals during the pandemic, taking these as lessons to better inform how
we can use telemedicine going forward. The COVID-19 pandemic has led to a rapid
expansion of the use of telemedicine, and many have had to adapt to the use of this
in diabetes care.